Cure rate of breast cancer lung metastasis

What is the cure rate of breast cancer lung metastasis? This is the most concerned issue for female patients. Breast cancer lung metastasis has a great impact on the patient's health. Breast cancer is easy to treat in the early stages, but once it is delayed to the late stages, it is quite difficult to cure. Therefore, we remind our compatriots to go to the hospital for regular check-ups to prevent the occurrence of the disease.

What is the cure rate of breast cancer lung metastasis? In order to prevent the occurrence of lung metastasis, comprehensive treatment measures mainly based on surgery are now adopted for breast cancer. Because even with extensive radical surgery, only local breast lesions and metastatic lymph nodes in adjacent areas can be removed; hidden cancer lesions that have been separated from the primary lesion and circulated to distant areas cannot be removed. These distant hidden lesions become the "living roots" that develop into metastatic cancer in the future. The purpose of comprehensive treatment such as surgery supplemented by radiotherapy, chemotherapy, endocrine therapy, and the combination of Chinese and Western medicine is to strive to control and eliminate these "living roots" to avoid recurrence and metastasis.

In order to find the signs of metastasis in time, breast cancer patients must insist on regular checkups. They should pay attention to any physical discomfort, especially the "clues" of the lung respiratory system. If any abnormality is found, relevant examinations should be carried out. If the signs of metastasis can be found in time and early, the effect is still very good through reasonable treatment.

Once lung metastasis is diagnosed, various treatments such as resection, minimally invasive surgery, interventional therapy, radiotherapy, chemotherapy, and a combination of Chinese and Western medicine can be used according to the scope and size of the metastatic lesions. It is important for breast cancer patients to adhere to endocrine therapy after surgery to prevent the recurrence of breast cancer.